UniProt ID ▲ | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A8C8YCN0 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C8YHB0 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C8YIL2 | ATP receptor |
|
1 | 0 |
|
A0A8C8YIU3 | Protein adenylyltransferase FICD |
|
1 | 0 |
|
A0A8C8YJI8 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A8C8YK29 | Rhodopsin |
|
2 | 0 |
|
A0A8C8YKQ2 | Pannexin |
|
1 | 0 |
|
A0A8C8YL21 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C8YL38 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C8YLH0 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C8YPI2 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C8YPP5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C8YR71 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C8YRA4 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A8C8YTY2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C8YUC7 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C8YUG3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C8YW84 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A8C8YXP6 | Hyaluronidase |
|
1 | 0 |
|
A0A8C8YXX7 | Potassium two pore domain channel subfamily K member 17 |
|
1 | 0 |
|
A0A8C8Z1R1 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C8Z366 | Paraoxonase |
|
2 | 0 |
|
A0A8C8Z393 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
2 | 0 |
|
A0A8C8Z3C2 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
3 | 0 |
|
A0A8C8Z594 | Paraoxonase |
|
2 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024